Cefdinir Powder, For Suspension
Product Images NDC 68071-3609

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68071-3609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3609 6)

Cefdinir 125 mg/5 mL oral suspension powder label from NuCare Pharmaceuticals, Inc. The 60 mL bottle label states reconstitution instructions with each 5 mL containing 125 mg Cefdinir USP. It includes barcode, NDC 68071-3609-6, storage instructions to keep out of reach of children and store at controlled temperature 68-77°F, and regulatory text with lot, expiration dates, and manufacturer details.*

FDA Label Image

Cefdinir (9ecd5d81 Ece0 4a98 9e1a 28651be48f75 01)

Chemical structure diagram of cefdinir showing its molecular framework with labeled atoms and bonds, representing the active ingredient cefdinir used in the oral powder for suspension formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.